Advancements of artificial intelligence in Chinese herbal medicine recommendation: A comprehensive review of data-driven approaches and clinical applications form 2016 to 2025
Abstract
Chinese herbal medicine recommendations are a core part of personalized traditional Chinese medicine (TCM) diagnosis and treatment. However, the complexity of the multidimensional relationships in syndrome differentiation and treatment, herbal compatibility, and dosage selection poses significant challenges to clinical decision-making. Although artificial intelligence technology has made remarkable progress in TCM auxiliary diagnosis, a systematic review of Chinese herbal medicine recommendation methods remains lacking. This review aims to address this gap by systematically reviewing Chinese herbal medicine generation methods grounded in knowledge graph-based recommendations, deep learning-based recommendations, and hybrid model-based recommendations from 2016 to 2025. Major TCM databases that serve as foundational data sources, including traditional Chinese medicine systems, pharmacology database, and analysis platform, symptom mapping database, High-throughput Experimental and Reference Database, and Traditional Chinese Medicine Information Database, which are crucial for training these recommendation models. It further analyses their evolutionary technical patterns and clinical applicability, providing critical references for developing theoretically robust and clinically interpretable artificial intelligence models for TCM practice. Existing research focuses on constructing knowledge graph-driven Chinese herbal medicine recommendation models, which enhance the…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.